US Patent 9493813 Modulation of phosphatidylinositol-5-phosphate-4-kinase activity
Patent 9493813 was granted and assigned to Beth Israel Deaconess Medical Center on November, 2016 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9493813 Modulation of phosphatidylinositol-5-phosphate-4-kinase activity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
